In 1987 was created MedImmune, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Maryland.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the MedImmune, startups are often financed by Sofinnova Partners, Apple Tree Partners. The meaningful sponsors for the fund in investment in the same round are Venrock Healthcare Partners, Venrock, Sofinnova Partners. In the next rounds fund is usually obtained by Auven Therapeutics, AstraZeneca, Redmile Group.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Corvidia Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Genetics, Medical.
The top activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.
This organization was formed by Wayne Hockmeyer.
Fund Name | Location |
AlphaCoin Fund | Boston, Massachusetts, United States |
Arcadia Funds | Burlington, Massachusetts, United States |
BERRIUP | Autonomous Community of the Basque Country, San Sebastián, Spain |
Bitrise Capital | Central, Central Region, Singapore |
Boyue Changxing Industrial | China, Hubei, Wuhan Shi |
Chengdu Mengting Electronic Commerce | Chengdu, China, Sichuan |
CoFound Partners | New York, New York, United States |
Dongzhao Shanghai Group | - |
Jinsheng Capital | - |
Klinkert Investment Trust | - |
Laconia | New York, New York, United States |
Litera Investments | Canada, London, Ontario |
London Startup Society | England, London, United Kingdom |
New Wheel Capital | - |
SC Digital Media | Japan, Tokyo |
Shoko Chukin Bank | New York, New York, United States |
Sorenson Development | - |
SSE | Australia, Perth, Western Australia |
Xizang Tongmei Wenhua | Chengguan District, China, Lhasa |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Corvidia | $60M | 25 Apr 2018 | Massachusetts, United States | ||
ADC Therapeutics | $40M | 16 Oct 2013 | Lausanne, Vaud, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Corvidia | $60M | 25 Apr 2018 | Massachusetts, United States | ||
ADC Therapeutics | $40M | 16 Oct 2013 | Lausanne, Vaud, Switzerland |